Leading Korean Pharma Companies Issued Fines In First Court Intervention Case Over Rebates
This article was originally published in PharmAsia News
Executive Summary
SEOUL - In the first court-involved case over rebates, three leading local South Korean pharma companies were issued stiff fines for "excessively unfair" business practices incurred by providing rebates to doctors and hospital